Article Details

China's Ascentage Snatches First Biotech IPO Price of 2025, Raking in $126M - GeneOnline

Retrieved on: 2025-01-24 18:51:41

Tags for this article:

Click the tags to see associated articles and topics

China's Ascentage Snatches First Biotech IPO Price of 2025, Raking in $126M - GeneOnline. View article details on hiswai:

Summary

The article discusses Ascentage Pharma's successful biotech IPO, raising $126 million in the U.S. amidst a resurgence in licensing Chinese-developed drugs. Linked to 'Biotech,' it involves key players like Takeda and mentions geographic significance like China.

Article found on: www.geneonline.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up